CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors

Clinical trial NCT05410717 · RECRUITING

Trial details

NCT number: NCT05410717
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Stage IV Ovarian Cancer Testis Cancer, Refractory Endometrial Cancer Recurrent CAR NK

Start date: 2022-06-01
Primary completion: 2030-06-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.